NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Exactics

Exactics

Private
Chicago, IllinoisHealthcare & Life Scienceshttps://www.exacticsbiotech.com/

Last Round

Seed Round

Jun 25, 2026

Total Funding Raised

$3.46M

Momentum

Top 25%

of companies Caplight tracks

Company Overview

Exactics is a biotechnology company that develops affordable, accurate, and accessible at-home rapid diagnostic tools for infectious diseases using its proprietary Proteus+ platform.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Medical Devices, D2C Brands

Business Model

B2C

Customer Profile

Hardware Sales, Hardware + Subscription

AI Layer

Non-AI

Keywords

at-home diagnosticrapid diagnostic testpoint-of-need testinglateral flow assayLyme disease testhome health kitveterinary diagnosticsinfectious disease testingdiagnostic platformdirect-to-consumerD2Cmedical devicebiotech startuphealth tech

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Exactics Comparables

Compare Exactics with similar companies based on industry and business-model similarity.

Exactics comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
LymeAlert
93%
MedZu Inc.
69%
Pfizer
69%

Exactics Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Seed RoundJun 25, 2026
GrantMar 10, 2026
SeedNov 21, 2025
SeedJul 6, 2025
GrantMay 29, 2025
Grant
Apr 18, 2025

Key People

Founding team and executive leadership

Maxwell Almeida

Co-Founder & Chief Technology Officer

Founding Team

Zachary Sarmoen

Co-Founder & Chief Financial Officer

Founding Team

Julian Kage

Chairman and Chief Executive Officer

Executive Team

Madeline Murray

Chief Operating Officer

Executive Team

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jun 25, 2026

    $855K raised in Seed Round.

  • Mar 11, 2026

    Attended the 2026 Tulane Business Model Competition.

Exactics Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Exactics Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Exactics's valuation, stock price, and market status.

Firmographic Details

HeadquartersChicago, Illinois
Employee Range9
Year Founded2021
Last FundingJun 25, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.